Kainic acid neurotoxicity: in vivo test of two new non-N-methyl-D-aspartate receptor antagonists
- PMID: 1829311
- DOI: 10.1007/BF00305866
Kainic acid neurotoxicity: in vivo test of two new non-N-methyl-D-aspartate receptor antagonists
Abstract
The possible neuroprotective effects of two new non-N-methyl-D-aspartate receptor antagonists were determined by quantitative light microscopy after intracerebral administration of kainic acid (KA) in two rat brain regions. KA alone or KA in combination with the antagonists alpha-amino-3-carboxy-methoxy-5-methyl-4-isoxazolepropionic acid (AMOA) and alpha-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)methyl-5-methyl-3 -oxo-4-isoxazoline-4-propionic acid (AMNH) were stereotaxically injected into the striatum or into the CA3 region of hippocampus. Seven days later neuropathological examination including cell counts was performed on paraffin sections from the two brain regions. In the striatum, AMOA almost completely attenuated KA-induced cell damage, whereas AMNH showed no protective effect. In the hippocampal CA3 region none of the test compounds possessed neuroprotective properties against KA. These results seem to be consistent with a difference in the mechanisms responsible for the neurotoxic action of KA in the hippocampus compared to the striatum.
Similar articles
-
The pyrimidine derivative BW 1003C87 protects against excitotoxic lesions induced by kainate in the rat striatum.Neurosci Lett. 1994 Sep 26;179(1-2):17-20. doi: 10.1016/0304-3940(94)90924-5. Neurosci Lett. 1994. PMID: 7531313
-
Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.Brain Res. 2001 Oct 26;917(1):21-44. doi: 10.1016/s0006-8993(01)02900-6. Brain Res. 2001. PMID: 11602227
-
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.J Med Chem. 1991 Jan;34(1):123-30. doi: 10.1021/jm00105a019. J Med Chem. 1991. PMID: 1825114
-
The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.Cerebrovasc Brain Metab Rev. 1994 Fall;6(3):225-56. Cerebrovasc Brain Metab Rev. 1994. PMID: 7529037 Review.
-
Therapeutic potential of NMDA antagonists in neurodegenerative diseases.Neurobiol Aging. 1994 Mar-Apr;15(2):271-3. doi: 10.1016/0197-4580(94)90131-7. Neurobiol Aging. 1994. PMID: 7838310 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous